ZetrOZ Systems to Present Wearable Ultrasound Technology at AAOS Annual Meeting

Feb 19

TRUMBULL, Conn., February 13, 2024 (VSNewsNetwork.com) - ZetrOZ Systems, the medical technology company behind the sam® wearable ultrasound unit, will showcase its sustained acoustic medicine technology at the American Academy of Orthopedic Surgeons (AAOS) annual meeting, taking place from February 12-16, 2024, in San Francisco. The event, hosted at the Moscone Center, is a global gathering of orthopedic surgeons aimed at advancing patient care through the exploration of the latest innovations in orthopedics.

According to the company, At the AAOS meeting, ZetrOZ Systems will feature its sam® 2.0 and sam® X1 devices at Booth 5301. These FDA-cleared devices offer a non-invasive, drug-free approach to soft tissue healing, supported by 42 peer-reviewed publications and 20 clinical studies across Levels 1-5. The technology operates on the principle of low-intensity, long-duration ultrasound treatment, which enhances blood flow and oxygenation while facilitating cellular regeneration and pain reduction.

George K. Lewis, a biomedical engineer and the CEO of ZetrOZ Systems, emphasized the impact of their technology, stating, “We’re pleased to be able to present our sam® devices and sustained acoustic medicine to the world’s leading orthopedic surgeons and offer them another methodology for helping their patients recover from injury.”

Lewis further expressed the company's mission, stating, “Thousands of physicians and health care professionals have already used our sam® technology to treat more than 300,000 patients, and we hope to bring its capabilities to the 50 million Americans who have access to the treatment.”

The sam® 2.0 and sam® X1 devices, designed for convenience and daily wear, are particularly beneficial for patients with arthritis and chronic injuries, offering an alternative to surgery or pain medication for some individuals. The treatment protocol typically involves daily application for one to four hours over a period of six to eight weeks, depending on the specific injury.

For additional information about ZetrOZ Systems and its sam® technology, visit www.zetroz.com

Source: ZetrOZ Systems via Newswire